Tag: Copycat drugs
Major shareholders are considering billion-dollar deal with financial investor
Sandoz Novartis announced in October that it would initiate a strategic review of its generics business, Sandoz. Photo: Sandoz Frankfurt According to circles, the Strüngmann family behind the Covid vaccine…
Major shareholders are considering a billion-dollar deal in the pharmaceutical sector
Sandoz Novartis announced in October that it would initiate a strategic review of its generics business, Sandoz. Photo: Sandoz Frankfurt According to circles, the Strüngmann family behind the Covid vaccine…
Novartis is considering selling generics business
Novartis logo on the roof in Basel In the third quarter, sales grew five percent on constant currency to $ 13.03 billion and adjusted operating income grew nine percent to…